FOR IMMEDIATE RELEASE First-Ever Multicenter Study of Hypothermic Oxygenated Perfusion (HOPE) with VitaSmart™ in Pediatric Liver Transplants Confirms Safety and Favorable Outcomes Groundbreaking: The first multicenter study in any machine perfusion device,
Abstracts to highlight hypothermic oxygenated perfusion (HOPE) in liver transplants, including pediatric patients Chicago, May 15, 2025 Bridge to Life™ Ltd., a leader in organ preservation solutions and perfusion technology, today announced the
FOR IMMEDIATE RELEASE First-Ever Comparative Study of Hypothermic Oxygenated Machine Perfusion (HOPE) with Normothermic Machine Perfusion (NMP) in Liver Transplantation Shows Better Outcomes With HOPE New data presented during Plenary Session at
Ownership Strengthens Bridge to Life's Position in Organ Preservation and Solidifies Enterprise Value Chicago, December 18, 2024 – Bridge to Life Ltd., a leader in organ preservation solutions and perfusion technology, has
Chicago, November 14, 2024 – Bridge to Life Ltd., a leading provider of organ preservation solutions and organ perfusion equipment, has announced that more than 5,0001 liver perfusions worldwide have
